Covalon Technologies (CVE:COV) Stock Price Down 16.7% - Time to Sell?

Key Points

• Covalon Technologies Ltd. experienced a significant stock drop of 16.7%, with shares trading down to C$2.40 from a previous close of C$2.88.
• The company has a high debt-to-equity ratio of 3.28 and strong liquidity measures, indicated by a current ratio of 7.27 and a quick ratio of 6.45.
• Covalon focuses on developing medical products for infection management and wound care, serving markets in North America, the Middle East, Asia, and Latin America.

Covalon Technologies Ltd. (CVE:COV - Get Free Report) was down 16.7% on Friday . The stock traded as low as C$2.36 and last traded at C$2.40. Approximately 181,028 shares changed hands during mid-day trading, an increase of 555% from the average daily volume of 27,638 shares. The stock had previously closed at C$2.88.

Covalon Technologies Trading Down 1.2%

The company has a current ratio of 7.27, a quick ratio of 6.45 and a debt-to-equity ratio of 3.28. The firm has a fifty day simple moving average of C$2.52 and a two-hundred day simple moving average of C$2.50. The firm has a market cap of C$64.93 million, a PE ratio of 27.20 and a beta of 0.64.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.